Monica Corazza

Monica Corazza

Auto-generated profile, based on publicly available information

Monica Corazza

Section of Dermatology and Infectious Diseases, Department of Medical Sciences, University of Ferrara, Ferrara, Italy

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2009 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
MCM Corazza
M Corazza
MLMm Lauriola
Mm Lauriola
MZM Zappaterra
M Zappaterra
ABAnna Bianchi
Anna Bianchi
AVA Virgili
A Virgili

3 August 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
MCMonica Corazza
Monica Corazza
NSNatale Schettini
Natale Schettini
PZPierantonia Zedde
Pierantonia Zedde
ABAlessandro Borghi
Alessandro Borghi
Vulvar lichen sclerosus (VLS) is a chronic, distressing, inflammatory disease with an enormous impact on quality of life. Treatment goals are relieving symptoms, reversing signs and preventing anatomical changes. Despite the availability of numerous therapeutic options, treatment outcome may not be entirely satisfactory and a definitive cure does not exist. This may be due to the fact that the exact VLS etiopathogenesis remains unknown. The objectives of this paper were to review the most up-to-date knowledge on VLS etiopathogenesis and to consider the available therapies through the lens of a plausible pathogenetic model. An electronic search on both VLS etiopathogenesis and its treatment was performed using the National Library of Medicine PubMed database. Based on current knowledge, it is conceivable that various, heterogeneous environmental factors acting on a genetic background trigger an autoimmune, Th-1 response, which leads to a chronic inflammatory state. This, in turn, can determine both tissue and micro-vascular injury and activation of signaling pathways involved in fibroblast and collagen metabolism. This pathogenetic sequence may explain the effectiveness of anti-inflammatory treatments, mostly topical corticosteroids, in improving VLS clinical-pathological changes. Further deepening of the disease pathways will presumably allow key mediators to become new therapeutic targets and optimize the available treatments.

23 July 2014 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
AVA. Virgili
A. Virgili
ABAlessandro Borghi
Alessandro Borghi
GTG. Toni
G. Toni
SMS. Minghetti
S. Minghetti
MCM. Corazza
M. Corazza

1 November 2001 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
MCM Corazza
M Corazza
OCO Capozzi
O Capozzi
AVA Virgili
A Virgili

5 June 2013 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
AVA. Virgili
A. Virgili
SMS. Minghetti
S. Minghetti
ABAlessandro Borghi
Alessandro Borghi
MCM. Corazza
M. Corazza

2 August 2013 in Contact Dermatitis
Verified
Journal Article
Closed access
PDF file
MCMonica Corazza
Monica Corazza
ABAlessandro Borghi
Alessandro Borghi
RGRosella Gallo
Rosella Gallo
DSDonatella Schena
Donatella Schena
PPPaolo Pigatto
Paolo Pigatto
AVAnnarosa Virgili
Annarosa Virgili